The analyzed RBBP8 promoter region was also unmethylated in 33 further cancerous cell lines, i.e., cell lines from breast cancer, lung cancer, prostate cancer, colorectal cancer, and renal cancer (see the complete list in Additional file 7). Here, RBBP8 is linked to breast carcinoma.